The sequential reaction of YCl 3 (THF) 3.5 with [ t -BuC(N i -Pr) 2 ]Li (Li[ A ]) and 2 equiv of LiCH(SiMe 3 ) 2 gave the mono(amidinate) dialkyl yttrium complex [ t -BuC(N i -Pr) 2 ]Y[CH(SiMe 3 ) 2 ] 2 (μ-Cl)Li(THF) 3 ( 1 ), which was structurally characterized. Use of the potentially tridentate amidinate−amine ligands [PhC(NSiMe 3 )N(CH 2 ) n NMe 2 ] - ( n = 2, B; 3, C ) yielded the salt-free dialkyl complexes [PhC(NSiMe 3 )N(CH 2 ) n NMe 2 ]Y[CH(SiMe 3 ) 2 ] 2 ( n = 2, 2a; 3, 2b ). A structure determination of 2a showed the tridentate ligand to adopt an approximately meridional geometry. Attempts to prepare analogous benzyl or trimethysilylmethyl complexes with ligand B yielded the ate-complexes Li[PhC(NSiMe 3 )N(CH 2 ) 2 NMe 2 ] 2 Y(R) 2 (R = CH 2 Ph, 3a; CH 2 SiMe 3, 3b ). A crystal structure of 3a showed that the Li ion is encapsulated by two amidinate and two amine nitrogens. The increased spacer length between the amidinate and amine functionalities in ligand C prevented encapsulation of the Li ion, but still produced a bis(amidinate) yttrium benzyl complex, [PhC(NSiMe 3 )N(CH 2 ) 3 NMe 2 ] 2 YCH 2 Ph ( 4 ). In this compound only one of the two dimethylamino functionalities is coordinated to the metal center.
No takes yet. Share an insight, caveat, or question.
Bambirra et al. (2000) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: